Every Newborn-Reach Up Early Education Intervention for All Children- a Parent Group Intervention for School Readiness in Bangladesh, Nepal, and Tanzania (EN-REACH)

The goal of this clinical trial is to test the effect of a pre-primary education parent group intervention in children with and without disability in Nepal Bangladesh and Tanzania. The main question it aims to answer are:

  • What is the impact of a parent group intervention on primary school readiness in children aged 5-6 years old in three LMICs?
  • What is the feasibility and accessibility of a parent group intervention for these children?

Participants will attend parent group sessions every two weeks for a total of 9 sessions. Researchers will compare a control group to see if there are impacts on school readiness and child development.

Study Overview

Status

Active, not recruiting

Detailed Description

Vulnerable children, including those with neuro-developmental delays and disabilities, often face barriers in accessing early primary education, thus hindering progress toward Sustainable Development Goal 4.2. Evidence-based interventions are essential to enhancing inclusivity and establishing sustainable implementation strategies to address this challenge. This study, Every Newborn - Reach up Early Education Intervention for All Children (EN-REACH), builds on the previous Every Newborn- Simplified Measurement Integrating Longitudinal Neurodevelopmental and Growth (EN-SMILING) observational cohort study. This is a cluster randomized controlled trial (cRCT) to evaluate the effectiveness of a parenting group intervention program for enhancing school readiness in Bangladesh, Nepal, and Tanzania, and an embedded process evaluation to inform scalability and feasibility.

EN-REACH is a cRCT with 150 clusters to evaluate the impact of a parent training program led by trained parent-teacher facilitator pairs, focusing on children aged 4~6 years preparing for preschool. Approximately 500 participants from the EN-SMILING cohort at each site have been identified. A geographic information system will define ~50 clusters in each of the three countries, each with approximately ten parent-child dyads. Half the clusters will be randomly assigned to intervention and control groups. The primary outcome is "school readiness", assessed using the Measuring Early Learning Quality and Outcomes (MELQO) tool. Secondary outcomes include Intelligence Quotient, child functioning, growth, visual, and hearing assessments. Data will be collected at baseline, and post-intervention data following implementation of the parent group intervention sessions over approximately 5-months. Quantitative data on coverage and quality care, combined with qualitative insights from children, caregivers, facilitators, and stakeholders' perspectives, will be used to conduct a process evaluation applying the RE-AIM framework.

This trial focused on enhancing school readiness and cognitive abilities in young children, inclusive of those with disabilities, aims to bridge gap from home to early primary education. EN-REACH aims to provide insights into the effectiveness and acceptability of a co-designed disability-inclusive school readiness program in three countries, potentially impacting national, and global policies for all children, including those with disabilities.

Study Type

Interventional

Enrollment (Actual)

1651

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dhaka, Bangladesh
        • International Centre for Diarrheal Disease Research, Bangladesh
      • Lalitpur, Nepal
        • Golden Community
      • Dar Es Salaam, Tanzania
        • Muhimbili University of Health and Allied Sciences

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Children aged 4-6 years in study area
  • Children who completed previous EN-SMILING Study

Exclusion Criteria:

  • Children outside of age range
  • Children living outside of study area

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pre-Primary Intervention
Program consisting of 9 modules focussing on early learning, play, saftey, wellbeing, reading and writing will be delivered approximately every two weeks to groups of 10 parents from the intervention arm.
School readiness intervention
No Intervention: Control
No intervention delivered. Participants will attend any government pre-primary based programmes as standard of care.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring Early Learning Quality and Outcomes (MELQO Tool)
Time Frame: Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
School Readiness
Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
The Pediatric Evaluation of Disability Inventory
Time Frame: Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
Child Disability
Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Washington Group Questionnaire
Time Frame: Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
Child functioning
Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
The Wechsler Preschool & Primary Scale of Intelligence
Time Frame: Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
Child IQ
Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
Pre-school Register
Time Frame: Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
Pre-school attendance
Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
Mental Health Questionnaire
Time Frame: Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
Maternal Mental Health screen
Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
Pediatric Quality of Life Inventory (PEDSQL Tool)
Time Frame: Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)
Child and family quality of life
Baseline (children are aged 5-5.5 years) and 6 months later post intervention (children aged 5.5-6 years)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 3, 2022

Primary Completion (Estimated)

April 15, 2024

Study Completion (Estimated)

September 15, 2024

Study Registration Dates

First Submitted

February 29, 2024

First Submitted That Met QC Criteria

March 27, 2024

First Posted (Actual)

March 28, 2024

Study Record Updates

Last Update Posted (Actual)

March 28, 2024

Last Update Submitted That Met QC Criteria

March 27, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

Annonomysed primary outcome data will be made available along with the protocol and statistical analysis plan

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Child Development

Clinical Trials on Pre-Primary Intervention

Subscribe